Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | BARD1 |
| Variant | P669L |
| Impact List | missense |
| Protein Effect | loss of function |
| Gene Variant Descriptions | BARD1 P669L lies within BRCT domain 2 of the Bard1 protein (UniProt.org). P669L demonstrates Bard1 subcellular localization and Brca1, Palb2, and Rad51c interaction similar to wild-type Bard1, but results in impaired homology-directed DNA repair activity, decreased DNA repair post-irradiation, decreased H2A ubiquitination, and increased sensitivity to olaparib and cisplatin treatment in cultured cells (PMID: 39387837). |
| Associated Drug Resistance | |
| Category Variants Paths |
BARD1 mutant BARD1 inact mut BARD1 P669L |
| Transcript | NM_000465.4 |
| gDNA | chr2:g.214729004G>A |
| cDNA | c.2006C>T |
| Protein | p.P669L |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_000465.4 | chr2:g.214729004G>A | c.2006C>T | p.P669L | RefSeq | GRCh38/hg38 |
| Molecular Profile | Protein Effect | Treatment Approaches |
|---|---|---|
| BARD1 P669L | loss of function | Olaparib |